Descriptive study of alcohol detoxifications in an Internal Medicine Service
DOI:
https://doi.org/10.20882/adicciones.260Keywords:
detoxification, withdrawal, alcohol, CIWA-ArAbstract
Alcohol dependence is a chronic disease whose treatment begins with detoxification, followed by rehabilitation. We present a descriptive and retrospective study of 147 patients admitted to our unit during the period 2003-2005. Median age was 46.07 years, with 77.6% men and 22.4% women. Admission diagnosis was alcohol withdrawal syndrome in 31 patients (21.1%) and programmed alcohol detoxification in 116 patients (78.9%). On the CIWA-Ar scale: mild withdrawal, 100 patients (68.5%), moderate, 35 patients (24%), severe, 11 patients (7.5%). Mild group showed a statistically significantly lower proportion of hepatopathy, by comparison with the moderate and severe groups. Statistically significant differences were found between the mild and severe groups on comparing mean age, duration of stay, quantity of alcohol and parameters of chronic consumption (ferritine, fe, VCM, UBE, AST, bilirubin and Mg) for AST and bilirubin. There were 11 seizures: 4 patients from the programmed group, with mild withdrawal on the CIWA-Ar scale, and 7 patients with moderate-severe withdrawal. No relationship was found between patients’ intensity of withdrawal syndrome, age or sex. There was higher intensity on the CIWA-Ar score (moderate and severe) among patients who had already begun withdrawal syndrome, compared to those admitted on a planned detoxification programme. The CIWA-Ar is a useful tool for assessing withdrawal symptoms and risks of complication and for planning treatment. Clinical practice must provide patients with access to health resources for the appropriate treatment of their addiction, with standardized assistance during their stay in hospital.References
Anderson P, Baumberg B. El alcohol en Europa. Una perspectiva de salud pública. Institute of Alcohol Studies. Reino Unido. 2006.
Corrao G, Bagnardi V, Zambon A, La Vecchia C. A metaanalysis
of alcohol consumption and the risk of 15 diseases. Prev Med 2004; 38: 613-619.
Boffetta P, Hashibe M. Alcohol and cancer. Lancet Oncol 2006; 7: 149-156.
Willner LR, Reuben A. Alcohol and the liver. Curr Opin Gastroenterol 2005; 21: 323-330.
Harper C, Matsumoto I. Ethanol and brain damage. Curr Opin Pharmacol 2005; 5: 73-78.
http://www.who.int/whr/2002/en/Chapter5S.pdf
Guardia J, Jiménez-Arriero MA, Pascual F, Flórez G, Contel M. Guía Clínica para el tratamiento del alcoholismo. Socidrogalcohol. Valencia 2007.
Ozdemir V, Bremner KE, Naranjo CA. Treatment of alcohol withdrawal syndrome. Ann Med 1994; 26: 101-5.
Ceccanti M, Balducci G, Attilia ML, Romeo M. Diagnóstico, aproximación terapéutica y rehabilitación del alcohólico. Adicciones 1999; 11: 363-372.
Paille F, Bazot M, Favre JD. Objetivos, indicaciones y modalidades de desintoxicación en los alcohólicos. Adicciones 2000; 12: 245-254.
Valdés-Stauber J. Estrategias en el tratamiento de desintoxicación alcohólica. Adicciones 2003, 15: 351-368
Mayo-Smith MF. Management of alcohol intoxication and withdrawal. In Grahan AW, Schultz TK, Wilford BB. Principles of addiction medicine. 2d ed. Chevy Chase, Md: American Society of Addiction Medicine. 1998:
-440.
Sulivan JT, Sykora K, Schneiderman J, Naranjo CA, Sellers EM. Assessment of alcohol withdrawal: the revised Clinical Institute Withdrawal Assessment for Alcohol Scale (CIWA-Ar). Br J Addict 1989; 84: 1353-
Lohr RH. Treatment of alcohol withdrawal in hospitalizad patients. Mayo Clin Proc 1995; 70: 777-782
Chang PH, Steinberg MB. Alcohol withdrawal. Med Clin North Am 2001; 85: 1191-1212.
Wetterling T, Driessen M, Kanitz RD, Junghanns K. The severity of alcohol withdrawal is not age dependent. Alcohol and Alcoholism 2001; 36: 75-78.
Wright T, Myrick H, Henderson S, Peters H, Malcolm R. Risk factors for delirium tremens: a retrospective chart review. Am J Addict 2006; 15: 213-219.
Wilson A and Vulcano B. A double-blind, placebocontrolled trial of magnesium sulphate in the ethanol withdrawal syndrome. Alcohol Clin Exp Res 1984; 8:542-545.
Schuckit M, Tipp J, Reich T, Hesselbrock V, Bucholz K. The histories of withdrawal convulsions and delirium tremens in 1648 alcohol dependent subjects. Addiction 1995; 90: 1335-1347.
Ait-Daoud N, Maolcolm RJ, Johson BA. Symptomtriggered vs fixed-schedule doses of benzodiacepine for alcohol withdrawal. Arch Intern Med 2002; 162:1117-1121.
Mayo-Smith MF, Beecher LH, Fischer TL, Gorelick DA, Guillaume JL, Hill A et al. Working Group on the Management of Alcohol Withdrawal delirium. An evidence-based practice guideline. Arch Intern Med
; 164: 1415-1412.
Soler PA, Guardia J. Tratamiento farmacológico: la desintoxicación. En: Monografía Alcohol. Ed. Pascual F, Torres M, Calafat A. Adicciones 2002, 13: 421-438.
Puz Ca, Strokes SJ. Alcohol withdrawal syndrome: assessment and treatment with the use of the Clinical Institute Withdrawal Assessment for Alcohol-revised. Crit Care Nurs Clin North Am 2005; 17: 297-304.
Polycarpou A, Papanikolaou P, Ioannidis JPA, Contopoulos-Ioannidis DG. Anticonvulsivantes para el síndrome de abstinencia alcohólica (Revisión Cochrane traducida). En: La Biblioteca Cochrane Plus, 2006
Número 1. Oxford: Update Software Ltd.
Ait-Daoud N, Maolcolm RJ, Johson BA. An overview of medications for the treatment of alcohol withdrawal and alcohol dependence with an amphasis on the use of older and newer anticonvulsivants. Addict Behav
; 31: 1628-1649
Brett Y. Lu, Coberly R. Use of oxcarbazepine in outpatient alcohol detoxification. Am J Addict 2005; 14: 191-192.
Johnson M, Brems C, Mills M, Fisher D. Psychiatric symptomatology among individuals in alcohol detoxification treatment. Addictive Behaviors 2007.
Casas M, Guardia J. Patología psiquiátrica asociada al alcoholismo. Adicciones 2002, vol 14 supl 1.
Diagnostic and statistical manual of mental disorders (DSM-IV-TR). 4th edn., text revision. American Psychiatric Association, Washington, DC, 2000, pp 212-214.
